Man Group PLC Sarepta Therapeutics, Inc. Transaction History

Man Group PLC

$37.6 Billion
Q2 2024

A detailed history of Man Group PLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Man Group PLC holds 386,424 shares of SRPT stock, worth $43.5 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

386,424

Previous 120,005 222.01%

Holding current value

$43.5 Million

Previous $15.5 Million 293.01%

% of portfolio

0.16%

Previous 0.04%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$113.33 - $163.85 $30.2 Million - $43.7 Million	266,419 Added 222.01%	386,424 $61.1 Million
Q1 2024 May 15, 2024	BUY	$93.7 - $141.53 $11.2 Million - $17 Million	120,005 New	120,005 $15.5 Million
Q1 2023 May 15, 2023	SELL	$117.53 - $155.99 $9.42 Million - $12.5 Million	-80,179 Reduced 98.09%	1,565 $215,000
Q4 2022 Feb 14, 2023	BUY	$100.86 - $132.13 $1.04 Million - $1.37 Million	10,344 Added 14.49%	81,744 $10.6 Million
Q3 2022 Nov 14, 2022	BUY	$75.71 - $119.24 $5.04 Million - $7.94 Million	66,629 Added 1396.54%	71,400 $7.89 Million
Q2 2022 Aug 15, 2022	SELL	$62.69 - $88.44 $736,482 - $1.04 Million	-11,748 Reduced 71.12%	4,771 $357,000
Q1 2022 May 16, 2022	BUY	$63.15 - $90.42 $1.04 Million - $1.49 Million	16,519 New	16,519 $1.29 Million
Q4 2021 Feb 14, 2022	SELL	$77.28 - $99.42 $2.46 Million - $3.16 Million	-31,819 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$65.97 - $92.48 $927,736 - $1.3 Million	14,063 Added 79.2%	31,819 $2.94 Million
Q2 2021 Aug 16, 2021	BUY	$69.38 - $86.75 $520,211 - $650,451	7,498 Added 73.09%	17,756 $1.38 Million
Q1 2021 May 17, 2021	BUY	$72.25 - $168.95 $1,589 - $3,716	22 Added 0.21%	10,258 $765,000
Q4 2020 Feb 16, 2021	SELL	$125.56 - $178.74 $3.79 Million - $5.39 Million	-30,177 Reduced 74.67%	10,236 $1.75 Million
Q3 2020 Nov 16, 2020	SELL	$127.12 - $172.34 $259,070 - $351,228	-2,038 Reduced 4.8%	40,413 $5.68 Million
Q2 2020 Aug 14, 2020	BUY	$93.0 - $171.7 $3.95 Million - $7.29 Million	42,451 New	42,451 $6.81 Million
Q4 2019 Feb 18, 2020	SELL	$76.53 - $135.58 $1.32 Million - $2.34 Million	-17,254 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$72.81 - $156.91 $1.05 Million - $2.27 Million	-14,446 Reduced 45.57%	17,254 $1.3 Million
Q2 2019 Aug 14, 2019	SELL	$112.21 - $151.95 $906,881 - $1.23 Million	-8,082 Reduced 20.32%	31,700 $4.82 Million
Q1 2019 May 15, 2019	BUY	$106.67 - $151.68 $3.98 Million - $5.65 Million	37,282 Added 1491.28%	39,782 $4.74 Million
Q4 2018 Feb 14, 2019	SELL	$97.32 - $148.76 $626,254 - $957,270	-6,435 Reduced 72.02%	2,500 $273,000
Q3 2018 Nov 14, 2018	BUY	$115.31 - $161.51 $742,019 - $1.04 Million	6,435 Added 257.4%	8,935 $1.44 Million
Q2 2018 Aug 14, 2018	BUY	$71.74 - $153.69 $179,350 - $384,225	2,500 New	2,500 $330,000

Others Institutions Holding SRPT

# of Institutions

547

Shares Held

87M

Call Options Held

3.69M

Put Options Held

1.79M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.85B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account